Picture of Assertio Holdings logo

ASRT — Assertio Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Assertio rises on Q2 profit beat, FY revenue forecast raise

** Shares of Assertio Holdings Inc  ASRT.O  rise 8.7% to
$4.3 before the bell
    ** Drugmaker raises its FY 2022 revenue forecast to a range
of $129 mln to $137 mln from $126 mln to $136 mln  urn:newsml:reuters.com:*:nGNX7L7JXK
    ** Reports Q2 adjusted net profit of 28 cents per share,
surging past estimates of 8 cents per share - Refinitiv IBES
Data
    ** Co's Q2 sales increased 40% to $35.4 mln on higher demand
for its bacterial infection drug, Indocin
    ** Up to Friday's close, stock up 83% YTD

 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))

Recent news on Assertio Holdings

See all news